| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |